About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 871 record(s)
Req # A-2023-001337
Names of all Health Canada Media Relations staff employed in the National Capital Region on January 24, 2024; Names of all Media Relations staff on duty that day thru the office associated with the Media Contact telephone number 613-957-2983; Name(s…Organization: Health Canada
February 2024
Req # A-2023-001344
Provide records showing your agency’s annual spending on advertising during the fiscal years of 2019-2020 to 2022-2023, and partial fiscal year 2023-2024 until the end of December 2023.Organization: Health Canada
February 2024
Req # A-2020-000850
Adverse Drug Reactions (ADRs). Report numbers: E2B_03195128, E2B_03196066, E2B_03198278, E2B_03198292.Organization: Health Canada
January 2024
Req # A-2021-000440
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 21-100203-189, Status of the use of Remotely Piloted Aircraft Systems (drones) for pesticide application in Canada.Organization: Health Canada
January 2024
Req # A-2021-001787
Adverse Drug Reaction (ADR) for AGALSIDASE BETA. Report number: E2B_04595165.Organization: Health Canada
January 2024
Req # A-2022-000123
Adverse Drug Reaction (ADR) for ALFUZOSIN HYDROCHLORIDE. Report number: E2B_05007203.Organization: Health Canada
January 2024
Req # A-2023-000126
Adverse Drug Reactions (ADRs). Report numbers: E2B_00675714, E2B_02977829, E2B_03128456.Organization: Health Canada
January 2024
Req # A-2023-001017
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 23-107682-242, Deputy Ministerial Meeting with Helium Developers Association of Canada.Organization: Health Canada
January 2024
Req # A-2023-001167
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 23-109485-722, Deputy Ministerial Meeting with the President and Chief Executive Officer of The Ottawa Hospital.Organization: Health Canada
January 2024
Req # A-2023-000483
A list of every drug approved under Health Canada's Special Access Program (SAP) between January 1, 2018 and July 6, 2023.Organization: Health Canada
January 2024